When Cytochrome P450 Inhibition Becomes a Drug Designer’s Best Friend
A new review argues that cytochrome P450 inhibition, long treated as a drug-discovery liability, can be a powerful therapeutic strategy ...
A new review argues that cytochrome P450 inhibition, long treated as a drug-discovery liability, can be a powerful therapeutic strategy ...
A potash alum-catalyzed microwave process produced eleven spiro-benzothiazoles in 20 minutes, highlighting distinct anticancer, antioxidant and antibacterial lead compounds.
In the rapidly evolving landscape of drug discovery, the ability to predict drug–target interactions (DTIs) has emerged as a pivotal ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine